Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
J Infect Dis ; 226(1): 1-5, 2022 08 12.
Artigo em Inglês | MEDLINE | ID: mdl-35297493

RESUMO

Use of interleukin (IL-6) inhibitors has become one of the most complicated clinical issues in treating coronavirus disease 2019 (COVID-19). Recently, randomized open-label platform trials have found that IL-6 inhibitors have a beneficial effect on mortality in severe COVID-19. However, several questions arise around their mechanism of action in this disease, as well as how, when, and at which dose they should be used. IL-6 has both proinflammatory and anti-inflammatory effects, which may modulate the course of COVID-19, whose immunopathogenesis is driven by the innate immune system, autoantibodies, and interferon. Given that patients with delayed seroconversion against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein would be at the highest risk of complications beyond the second week of disease, we propose that considering patient serostatus at admission could optimize the use of IL-6 inhibitors in COVID-19. We predict that the net treatment benefits could be higher in the subgroup of patients with delayed seroconversion as compared to those who seroconvert more rapidly after SARS-CoV-2 infection.


Assuntos
Tratamento Farmacológico da COVID-19 , SARS-CoV-2 , Anticorpos Monoclonais Humanizados , Humanos , Interleucina-6 , Ensaios Clínicos Controlados Aleatórios como Assunto , Glicoproteína da Espícula de Coronavírus
2.
Clin Trials ; 12(3): 246-56, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25691600

RESUMO

BACKGROUND: The value of community-based cancer research has long been recognized. In addition to the National Cancer Institute's Community Clinical and Minority-Based Oncology Programs established in 1983, and 1991 respectively, the National Cancer Institute established the National Cancer Institute Community Cancer Centers Program in 2007 with an aim of enhancing access to high-quality cancer care and clinical research in the community setting where most cancer patients receive their treatment. This article discusses strategies utilized by the National Cancer Institute Community Cancer Centers Program to build research capacity and create a more entrenched culture of research at the community hospitals participating in the program over a 7-year period. METHODS: To facilitate development of a research culture at the community hospitals, the National Cancer Institute Community Cancer Centers Program required leadership or chief executive officer engagement; utilized a collaborative learning structure where best practices, successes, and challenges could be shared; promoted site-to-site mentoring to foster faster learning within and between sites; required research program assessments that spanned clinical trial portfolio, accrual barriers, and outreach; increased identification and use of metrics; and, finally, encouraged research team engagement across hospital departments (navigation, multidisciplinary care, pathology, and disparities) to replace the traditionally siloed approach to clinical trials. LIMITATIONS: The health-care environment is rapidly changing while complexity in research increases. Successful research efforts are impacted by numerous factors (e.g. institutional review board reviews, physician interest, and trial availability). The National Cancer Institute Community Cancer Centers Program sites, as program participants, had access to the required resources and support to develop and implement the strategies described. Metrics are an important component yet often challenging to identify and collect. The model requires a strong emphasis on outreach that challenges hospitals to improve and expand their reach, particularly into underrepresented populations and catchment areas. These efforts build on trust and a referral pipeline within the community which take time and significant commitment to establish. CONCLUSION: The National Cancer Institute Community Cancer Centers Program experience provides a relevant model to broadly address creating a culture of research in community hospitals that are increasingly networked via systems and consortiums. The strategies used align well with the National Cancer Institute-American Society of Clinical Oncology Accrual Symposium recommendations for patient-/community-, physician-/provider-, and site-/organizational-level approaches to clinical trials; they helped sites achieve organizational culture shifts that enhanced their cancer research programs. The National Cancer Institute Community Cancer Centers Program hospitals reported that the strategies were challenging to implement yet proved valuable as they provided useful metrics for programmatic assessment, planning, reporting, and growth. While focused on oncology trials, these concepts may be useful within other disease-focused research as well.


Assuntos
Pesquisa Biomédica/organização & administração , Hospitais Comunitários/organização & administração , National Cancer Institute (U.S.)/organização & administração , Neoplasias/terapia , Cultura Organizacional , Fortalecimento Institucional/organização & administração , Comportamento Cooperativo , Humanos , Relações Interinstitucionais , Liderança , Estados Unidos
3.
J Infect Dis ; 204(1): 139-44, 2011 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-21628668

RESUMO

BACKGROUND: Viral tropism influences the natural history of human immunodeficiency type 1 (HIV-1) disease: X4 viruses are associated with faster decreases in CD4 cell count. There is scarce information about the influence of viral tropism on treatment outcomes. METHODS: Baseline plasma samples from patients recruited to the ArTEN (Atazanavir/ritnoavir vs. Nevirapine on a background of Tenofovir and Emtricitabine) trial were retrospectively tested for HIV-1 tropism using the genotypic tool geno2pheno(FPR=5.75%). ArTEN compared nevirapine with atazanavir-ritonavir, both along with tenofovir-emtricitabine, in drug-naïve patients. RESULTS: Of 569 ArTEN patients, 428 completed 48 weeks of therapy; 282 of these received nevirapine and 146 of these received atazanavir-ritonavir. Overall, non-B subtypes of HIV-1 were recognized in 96 patients (22%) and X4 viruses were detected in 55 patients (14%). At baseline, patients with X4 viruses had higher plasma HIV RNA levels (5.4 vs 5.2 log copies/mL, respectively; P = .044) and lower CD4 cell counts (145 vs 188 cells/µL, respectively; P < .001) than those with R5 strains. At week 48, virologic responses were lower in patients with X4 viruses than in patients with R5 viruses (77% vs 92%, respectively; P = .009). Multivariate analysis confirmed HIV-1 tropism as an independent predictor of virologic response at week 24 (P = .012). This association was extended to week 48 (P = .007) in clade B viruses. Conversely, CD4 cell count recovery was not influenced by baseline HIV-1 tropism. CONCLUSIONS: HIV-1 tropism is an independent predictor of virologic response to first-line antiretroviral therapy. In contrast, it does not seem to influence CD4 cell count recovery. CLINICAL TRIALS REGISTRATION: NCT00389207.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Linfócitos T CD4-Positivos/imunologia , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/patogenicidade , Tropismo Viral , Contagem de Linfócito CD4 , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Plasma/virologia , Resultado do Tratamento
4.
J Clin Microbiol ; 49(9): 3380-2, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21734029

RESUMO

The agreement between the position-specific scoring matrix (PSSM) and geno2pheno as tools for genotypic interpretation of HIV-1 tropism using 800 clinical specimens was assessed. There was an overall concordance of 88%. Disagreement was found mostly in specimens with short V3 lengths (<35 amino acids). Thus, consideration of V3 lengths should improve the predictability of HIV-1 tropism using genotypic algorithms.


Assuntos
HIV-1/genética , HIV-1/patogenicidade , Tropismo Viral , Virologia/métodos , Produtos do Gene env do Vírus da Imunodeficiência Humana/classificação , Produtos do Gene env do Vírus da Imunodeficiência Humana/genética , Algoritmos , Genótipo , Infecções por HIV/virologia , Humanos , Dados de Sequência Molecular , Matrizes de Pontuação de Posição Específica , Análise de Sequência de DNA
5.
Am Soc Clin Oncol Educ Book ; 41: e339-e353, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34061565

RESUMO

Optimizing the well-being of the oncology clinician has never been more important. Well-being is a critical priority for the cancer organization because burnout adversely impacts the quality of care, patient satisfaction, the workforce, and overall practice success. To date, 45% of U.S. ASCO member medical oncologists report experiencing burnout symptoms of emotional exhaustion and depersonalization. As the COVID-19 pandemic remains widespread with periods of outbreaks, recovery, and response with substantial personal and professional consequences for the clinician, it is imperative that the oncologist, team, and organization gain direct access to resources addressing burnout. In response, the Clinician Well-Being Task Force was created to improve the quality, safety, and value of cancer care by enhancing oncology clinician well-being and practice sustainability. Well-being is an integrative concept that characterizes quality of life and encompasses an individual's work- and personal health-related environmental, organizational, and psychosocial factors. These resources can be useful for the cancer organization to develop a well-being blueprint: a detailed start plan with recognized strategies and interventions targeting all oncology stakeholders to support a culture of community in oncology.


Assuntos
Esgotamento Profissional/psicologia , Oncologia/métodos , Neoplasias/terapia , Oncologistas/psicologia , Estresse Psicológico/prevenção & controle , Esgotamento Psicológico/prevenção & controle , Esgotamento Psicológico/psicologia , COVID-19/epidemiologia , COVID-19/prevenção & controle , COVID-19/virologia , Humanos , Internet , Satisfação no Emprego , Oncologia/organização & administração , Neoplasias/diagnóstico , Pandemias , SARS-CoV-2/isolamento & purificação , SARS-CoV-2/fisiologia , Apoio Social , Estados Unidos
6.
Pest Manag Sci ; 77(2): 697-708, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32841479

RESUMO

BACKGROUND: Black-foot and Petri diseases are the main fungal diseases associated with young grapevine decline. Two field experiments were established to evaluate the preventive effect of two potential biocontrol agents (BCAs), that is Streptomyces sp. E1 + R4 and Pythium oligandrum Po37, and three BCA-commercial products containing Trichoderma atroviride SC1, Trichoderma koningii TK7 and Pseudomonas fluorescens + Bacillus atrophaeus on fungal infection in grafted plants and plant growth parameters. RESULTS: The effectiveness of some BCA in reducing the incidence and severity of both diseases was dependent on the plant part analyzed and the plant age. No single BCA application was able to control both diseases. Streptomyces sp. E1 + R4 were able to reduce significantly the infection of the most prevalent black-foot disease fungi while P. oligandrum Po37 and Trichoderma spp. were able to reduce significantly Phaeomoniella chlamydospora and Phaeoacremonium minimum (Petri disease) infection. BCA treatments had no effect on the shoot weight, and root weight was significantly lower in all BCA treatments with respect to the control. CONCLUSIONS: The combination of the disease-suppressive activity of two or more beneficial microbes in a biocontrol preparation is required to prevent infection by black-foot and Petri disease fungi in vineyards.


Assuntos
Vitis , Ascomicetos , Bacillus , Hypocreales , Doenças das Plantas/prevenção & controle
7.
Rev Salud Publica (Bogota) ; 22(6): 582-588, 2020 11 01.
Artigo em Espanhol | MEDLINE | ID: mdl-36753075

RESUMO

OBJECTIVE: To describe the relationship between obesity and proinflammatory variables in the student population of the University of Quindío. METHODS: A cross-sectional descriptive study in which 155 students participated. Firstly, the glycemia was made by conventional methods, the insulinemia and the cytokines were measured by ELISA; IMC and HOMA-IR index were calculated. Then, the information was analyzed in the Statgraphics software to establish relationships between the variables were established through multiple regression and thus statistically significant difference was considered when the p value was ≤0.05. RESULTS: The prevalence of obesity by BMI was of 4.6%, of overweight 20.5% and of abdominal obesity by waist circumference was of 18.5%. The average insulinemia was 8.5 pUI/ml ±6.4 and the HOMA-IR index was 1.75. 18.5% had insulin resistance. Interferon gamma was found at 4.6±12.0 pg/mL, IL-6 at 5.1±15.5 pg/mL and TNF alpha at 3.2±11.1 pg/mL. The greatest variation explained (R2) is presented by insulinemia, the waist/hip index and the Homa-IR index. IL-6 was the cytokine that presented the greatest variation explained. CONCLUSIONS: There is a relationship between inflammatory cytokines such as IL-6 with the waist/hip index, diastolic pressure, insulinemia and the Homa-IR index.


OBJETIVO: Describir la relación entre obesidad y variables proinflamatorias en la población estudiantil de la Universidad del Quindío. MÉTODOS: Estudio descriptivo de corte transversal en el cual participaron 155 estudiantes. En primer lugar se midió la glicemia -por métodos convencionales-, la insulinemia y las citocinas -mediante la prueba ELISA-; también se calculó IMC e índice HOMA-IR. Luego, esta información se analizó en el software Statgraphics con el fin de establecer relaciones entre las variables a través de regresión múltiple. Así, se llegó a una diferencia estadísticamente significativa cuando el valor de p fue ≤0,05. RESULTADOS: La prevalencia de obesidad por IMC fue de 4,6%; la de sobrepeso, 20,5%; y la de obesidad abdominal por perímetro de cintura fue de 18,5%. El promedio de insulinemia fue de 8,5 pUI/ml±6,4 y el índice HOMA-IR, de 1,7. El 18,5% presentaron resistencia a la insulina. El interferón gamma se encontró en 4,6±12,0 pg/mL; la IL-6, en 5,1±15,5 pg/mL; y el TNF alfa, en 3,2±11,1 pg/mL. La mayor variación explicada (R2) la presentan la insulinemia, el índice cintura/cadera y el índice Homa-IR. La IL-6 fue la citocina que presentó la mayor variación explicada. CONCLUSIONES: Se evidencia que existe una relación entre citocinas inflamatorias como la IL-6 con el índice cintura/cadera, la insulinemia y el índice Homa-IR y la presión diastólica.


Assuntos
Interleucina-6 , Obesidade , Humanos , Estudos Transversais , Colômbia/epidemiologia , Universidades , Índice de Massa Corporal , Obesidade/epidemiologia , Circunferência da Cintura , Inflamação/epidemiologia
8.
Circulation ; 117(14): 1864-72, 2008 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-18378611

RESUMO

BACKGROUND: The effect of prearrest left ventricular ejection fraction (LVEF) on outcome after cardiac arrest is unknown. METHODS AND RESULTS: During a 26-month period, Utstein-style data were prospectively collected on 800 consecutive inpatient adult index cardiac arrests in an observational, single-center study at a tertiary cardiac care hospital. Prearrest echocardiograms were performed on 613 patients (77%) at 11+/-14 days before the cardiac arrest. Outcomes among patients with normal or nearly normal prearrest LVEF (> or = 45%) were compared with those of patients with moderate or severe dysfunction (LVEF < 45%) by chi(2) and logistic regression analyses. Survival to discharge was 19% in patients with normal or nearly normal LVEF compared with 8% in those with moderate or severe dysfunction (adjusted odds ratio, 4.8; 95% confidence interval, 2.3 to 9.9; P<0.001) but did not differ with regard to sustained return of spontaneous circulation (59% versus 56%; P=0.468) or 24-hour survival (39% versus 36%; P=0.550). Postarrest echocardiograms were performed on 84 patients within 72 hours after the index cardiac arrest; the LVEF decreased 25% in those with normal or nearly normal prearrest LVEF (60+/-9% to 45+/-14%; P<0.001) and decreased 26% in those with moderate or severe dysfunction (31+/-7% to 23+/-6%, P<0.001). For all patients, prearrest beta-blocker treatment was associated with higher survival to discharge (33% versus 8%; adjusted odds ratio, 3.9; 95% confidence interval, 1.8 to 8.2; P<0.001). CONCLUSIONS: Moderate and severe prearrest left ventricular systolic dysfunction was associated with substantially lower rates of survival to hospital discharge compared with normal or nearly normal function.


Assuntos
Reanimação Cardiopulmonar , Parada Cardíaca/complicações , Pacientes Internados/estatística & dados numéricos , Volume Sistólico , Disfunção Ventricular Esquerda/etiologia , Antagonistas Adrenérgicos beta/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Dano Encefálico Crônico/epidemiologia , Dano Encefálico Crônico/etiologia , Doenças Transmissíveis/epidemiologia , Comorbidade , Feminino , Parada Cardíaca/terapia , Mortalidade Hospitalar , Hospitais Especializados , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/mortalidade , Pneumonia/epidemiologia , Estudos Prospectivos , Análise de Sobrevida , Sístole , Resultado do Tratamento , Ultrassonografia , Disfunção Ventricular Esquerda/diagnóstico por imagem
9.
Ann Diagn Pathol ; 13(4): 257-62, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19608084

RESUMO

The follicular dendritic cell sarcoma/tumor is a neoplasic proliferation of fusiform and ovoid cells with characteristic morphology and immunohistochemical pattern. The sarcoma/tumor term is designated due to the variability of the cytological status and, in many cases, its indeterminate clinical course. This report presents the 2 first cases seen at the Hospital General de México, OD (General Hospital of Mexico). The aim of this study is to contribute to the morphology and immunophenotype of this infrequent neoplasm, as well as discuss its differential diagnosis and clinical evolution.


Assuntos
Sarcoma de Células Dendríticas Foliculares/diagnóstico , Sarcoma de Células Dendríticas Foliculares/patologia , Linfoma/diagnóstico , Linfoma/patologia , Adulto , Sarcoma de Células Dendríticas Foliculares/imunologia , Diagnóstico Diferencial , Feminino , Humanos , Imunofenotipagem , Linfoma/imunologia , Pessoa de Meia-Idade , Receptores de Complemento 3b/metabolismo , Receptores de Complemento 3d/metabolismo
10.
Front Microbiol ; 8: 347, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28326067

RESUMO

Phytopathogenic fungi responsible for post-harvest diseases on fruit and vegetables cause important economic losses. We have previously reported that harmol (1-methyl-9H-pyrido[3,4-b]indol-7-ol) is active against the causal agents of green and gray molds Penicillium digitatum and Botrytis cinerea, respectively. Here, antifungal activity of harmol was characterized in terms of pH dependency and conidial targets; also photodynamic effects of UVA irradiation on the antimicrobial action were evaluated. Harmol was able to inhibit the growth of both post-harvest fungal disease agents only in acidic conditions (pH 5), when it was found in its protonated form. Conidia treated with harmol exhibited membrane integrity loss, cell wall disruption, and cytoplasm disorganization. All these deleterious effects were more evident for B. cinerea in comparison to P. digitatum. When conidial suspensions were irradiated with UVA in the presence of harmol, antimicrobial activity against both pathogens was enhanced, compared to non-irradiated conditions. B. cinerea exhibited a high intracellular production of reactive oxygen species (ROS) when was incubated with harmol in irradiated and non-irradiated treatments. P. digitatum showed a significant increase in ROS accumulation only when treated with photoexcited harmol. The present work contributes to unravel the antifungal activity of harmol and its photoexcited counterpart against phytopathogenic conidia, focusing on ROS accumulation which could account for damage on different cellular targets.

11.
Rev. salud pública ; 24(4)jul.-ago. 2022.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1536735

RESUMO

Objetivo Caracterizar la dispensa de antibióticos a pacientes ambulatorios en un instituto de seguridad social universitario durante el año 2020. Método Se realizó un estudio observacional, descriptivo-correlacional de utilización de medicamentos. Para cuantificar la dispensa, se utilizó la dosis diaria definida (DDD) por 1 000 habitantes por día (DHD) y la unidad de dosis, recomendadas por la Organización Mundial de la Salud (OMS), y el valor intrínseco terapéutico potencial como indicador cualitativo, según Laporte y Tognoni. Resultados Se incluyeron 4 748 dispensaciones ambulatorias. Edad promedio: 42 años; rango: 0-94 años, con predominio del sexo femenino (55%). La mayoría pertenecían al grupo de las penicilinas (51,3%) con predominio de amoxicilina en asociaciones a dosis fija o como monofármaco (48,3%), seguida por los macrólidos (21,0%) y las fluoroquinolonas (17,0%). Se pudo apreciar un consumo potencial de 7,7 DHD, lo cual implica que, en promedio, 7 de cada 1 000 afiliados de la institución estuvo expuesto a estos agentes diariamente, con predominio de amoxicilina asociada a ácido clavulánico (2,2 DHD). Conclusión La población general de universitarios estuvo expuesta a una prescripción alta de amoxicilina en asociaciones a dosis fijas, algunas de valor inaceptable o relativa, así como también a los nuevos macrólidos y fluoroquinolonas de segunda y tercera generación. Esto requiere especial atención, porque el consumo indiscriminado a nivel ambulatorio de antibióticos de amplio espectro podría convertirse en un factor de riesgo para el desarrollo de resistencia bacteriana; implica, además, un riesgo en la aparición de eventos adversos serios y un incremento en el gasto sanitario.


Objective To characterize the dispensing of antibiotics to outpatients of a university social security institute during the year 2020. Methods An observational, descriptive-correlational study of drug use was carried out. To quantify the dispensation, the defined daily dose (DDD) per 1 000 inhabitants per day (DHD) and the dose unit, recommended by the World Health Organization (WHO), were used. The classification of potential therapeutic intrinsic value, by Laporte and Tognoni, was used as a qualitative indicator. Results A total of 4 748 outpatient dispensations of antibiotics were included, 55% for the female sex. Average age: 42 years; range: 0-94 years. The majority belonged to the penicillin group (51.3%) with a predominance of amoxicillin (48.3%) in fixed-dose associations or mono-drug, followed by macrolides (21.0%) and fluoroquinolones (17.0%). A potential consumption of 7.7 DHD was observed, which implies that, on average, 7 out of every 1 000 members of the institution were exposed to these agents daily with a predominance of amoxicillin associated with clavulanic acid (2.2 DHD). Conclusion The general population of university students was exposed to high fixed-dose associations prescription of amoxicillin, some of relative or unacceptable potential therapeutic intrinsic value, as well as to the new macrolides and second or third generation of fluoroquinolones. This requires special attention because the indiscriminate outpatient use of broad-spectrum antibiotics could become a risk factor for the development of bacterial resistance. It also implies a higher risk of serious adverse events and an increase in healthcare costs.

12.
Am J Cardiol ; 119(2): 237-242, 2017 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-27823597

RESUMO

Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and/or pulmonary embolism (PE). Many surgeons and clinicians believe that VTE after coronary artery bypass grafting (CABG) has little clinical significance because it is seldom diagnosed. This study aimed to identify VTE after CABG, independent of clinical suspicion. In this prospective, observational, single-center study, 100 patients underwent computed tomographic pulmonary angiography (multidetector-64) and lower extremity venous compressive ultrasound after elective CABG. Patients with high risk for VTE were excluded. Aspirin was maintained throughout the preoperative and postoperative periods, and early ambulation was encouraged. Postoperatively, no mechanical or heparin prophylaxis was used in any patients. At the discretion of the surgeons, 83 surgeries were on-pump, and 17 were off-pump. On average, tomography and ultrasound were performed 7 ± 3 days after CABG. Isolated PE was observed in 13 of 100 patients (13%), simultaneous PE and DVT in 8 of 100 (8%), and isolated DVT in 4 of 100 (4%), thus totaling 25/100 VTEs (25%). Of the 21 PEs, 3 of 21 (14%) involved subsegmental, 15 of 21 (71%) segmental, 1 of 21 (5%) lobar, and 2 of 21 (10%) central pulmonary arteries. Of the 12 DVTs, all were distal (below the popliteal vein), and 2 of 12 (17%) were also proximal; 5 of 12 (42%) were unilateral, of which 3 of 5 (60%) on the contralateral saphenous vein-harvested leg. No VTE caused hemodynamic instability, and none was clinically suspected. In conclusion, VTEs were frequent, some extensive proximal VTEs occurred, but most were distally localized. Many patients in this series would have been discharged without diagnosis of and treatment for PE and/or DVT.


Assuntos
Ponte de Artéria Coronária/efeitos adversos , Doença da Artéria Coronariana/cirurgia , Embolia Pulmonar/epidemiologia , Trombose Venosa/epidemiologia , Idoso , Angiografia por Tomografia Computadorizada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Embolia Pulmonar/diagnóstico por imagem , Ultrassonografia , Trombose Venosa/diagnóstico por imagem
13.
Resuscitation ; 70(3): 356-9, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16901612

RESUMO

Emergency medical services in Brazil have been created to offer first aid, primary medical treatment, basic life support, stabilization and rapid transfer to the closest appropriate hospital and advanced life support. Pre-hospital emergency care in Brazil is divided into permanent and mobile services. Permanent care is provided by the pre-hospital network (basic health units, family health program, specialized clinics, diagnosis and therapy services, non-hospital emergency care units). The mobile medical services include: mobile emergency care service, fire department and private services. Emergency hospital care units (emergency departments) are classified into general and reference units. Details of these services are described.


Assuntos
Serviços Médicos de Emergência , Programas Nacionais de Saúde/organização & administração , Brasil , Educação Médica , Serviços Médicos de Emergência/provisão & distribuição , Meios de Transporte
14.
Rev Salud Publica (Bogota) ; 8 Suppl 1: 13-23, 2006 May.
Artigo em Espanhol | MEDLINE | ID: mdl-16925118

RESUMO

OBJECTIVES: Implementing environmental surveillance for poliovirus circulating from wastewater. METHODS: Six wastewater samples were collected from each final site within a wastewater collection system in Armenia, Quindío. Virus was extracted and concentrated by a method using polyethylenglycol and sodium chloride as concentrating agent. Polioviruses were identified by polymerase chain reaction assay with group-specific, serotype-specific and Sabin vaccine-specific primers. RESULTS: It was confirmed that the viral detection method is highly efficient. Poliovirus was detected in 5 of 6 (83%) samples collected. Serotype-specific identification revealed the presence of type 1 and type 3 polioviruses in the samples. All of them were of the vaccine type, which provided evidence regarding the non-circulation of wild poliovirus in the country. CONCLUSION: Wastewater surveillance can be a sensitive tool for detecting poliovirus circulation.


Assuntos
Poliovirus/isolamento & purificação , Esgotos/virologia , Colômbia , Microbiologia Ambiental , Poliovirus/classificação , Vacina Antipólio Oral , Polietilenoglicóis , RNA Viral/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Cloreto de Sódio , Virologia/métodos
15.
Ann Clin Lab Sci ; 46(5): 552-6, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27650625

RESUMO

Anaplastic transformation of well-differentiated thyroid carcinomas at distant metastatic sites is a rare condition. Most cases described in the literature have occurred in the thyroid or regional lymph nodes. We report a case of anaplastic transformation of the follicular variant of papillary thyroid carcinoma in mandibular metastases. A 76-year-old female presented with a painful and enlarging mandibular mass. She had been treated in the past for the follicular variant of papillary thyroid carcinoma. A palliative hemi-mandibulectomy was performed. Histology revealed a metastatic papillary thyroid carcinoma, follicular variant, with an unusual finding of solid pleomorphic epithelioid and spindle cell areas, consistent with anaplastic transformation.


Assuntos
Carcinoma Papilar, Variante Folicular/patologia , Carcinoma/patologia , Transformação Celular Neoplásica/patologia , Neoplasias Mandibulares/secundário , Carcinoma Anaplásico da Tireoide/patologia , Neoplasias da Glândula Tireoide/patologia , Idoso , Carcinoma Papilar , Feminino , Humanos , Imuno-Histoquímica , Neoplasias Mandibulares/diagnóstico por imagem , Neoplasias Mandibulares/patologia , Recidiva Local de Neoplasia/patologia , Câncer Papilífero da Tireoide , Tomografia Computadorizada por Raios X
16.
Rev Salud Publica (Bogota) ; 18(1): 95-103, 2016 Feb.
Artigo em Espanhol | MEDLINE | ID: mdl-28453157

RESUMO

Objective The main goal of this research was to assess the seroprevalence of antibodies against measles, rubella, mumps, hepatitis B and all three poliovirus serotypes among children in the Quindío Department, Colombia. Methods Blood samples were obtained from 170 healthy children aged 5-9 years from nine municipalities in Quindío. The presence of serum IgG antibodies against measles, rubella, mumps and Hepatitis B were determined using commercial indirect ELISA kits. Immunity to poliomyelitis was assessed through the presence of neutralizing antibodies following the method recommended by the World Health Organization. Results Among the 170 children enrolled, 169 (99.41%), 170 (100 %), and 167 (98.2 %) were seropositive to poliovirus 1, poliovirus 2, and poliovirus 3, respectively. The average reciprocal antibody titers were 178 for poliovirus type 1, 120 for type 2 and 56 for type 3. Of the 170 children, 96.47 % were protected against mumps and rubella, and 86.47 % against measles. Only 106 (62.35 %) of the studied subjects were proved to be seropositive to hepatitis B. Conclusion The immunization program in Quindío has provided seroprotection against all three poliomyelitis serotypes, rubella and mumps. However, the child population is not fully protected against measles and hepatitis B virus infections.


Assuntos
Anticorpos Antivirais/sangue , Vírus da Hepatite B/imunologia , Sarampo/imunologia , Caxumba/imunologia , Poliovirus/imunologia , Rubéola (Sarampo Alemão)/imunologia , Criança , Pré-Escolar , Colômbia , Estudos Transversais , Humanos , Imunoglobulina G/sangue , Estudos Soroepidemiológicos
17.
Rev. salud pública ; 22(6): e203, nov.-dic. 2020. tab
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1252090

RESUMO

RESUMEN Objetivo Describir la relación entre obesidad y variables proinflamatorias en la población estudiantil de la Universidad del Quindío. Métodos Estudio descriptivo de corte transversal en el cual participaron 155 estudiantes. En primer lugar se midió la glicemia -por métodos convencionales-, la insulinemia y las citocinas -mediante la prueba ELISA-; también se calculó IMC e índice HOMA-IR. Luego, esta información se analizó en el software Statgraphics con el fin de establecer relaciones entre las variables a través de regresión múltiple. Así, se llegó a una diferencia estadísticamente significativa cuando el valor de p fue ≤0,05. Resultados La prevalencia de obesidad por IMC fue de 4,6%; la de sobrepeso, 20,5%; y la de obesidad abdominal por perímetro de cintura fue de 18,5%. El promedio de insulinemia fue de 8,5 pUI/ml±6,4 y el índice HOMA-IR, de 1,7. El 18,5% presentaron resistencia a la insulina. El interferón gamma se encontró en 4,6±12,0 pg/mL; la IL-6, en 5,1±15,5 pg/mL; y el TNF alfa, en 3,2±11,1 pg/mL. La mayor variación explicada (R2) la presentan la insulinemia, el índice cintura/cadera y el índice Homa-IR. La IL-6 fue la citocina que presentó la mayor variación explicada. Conclusiones Se evidencia que existe una relación entre citocinas inflamatorias como la IL-6 con el índice cintura/cadera, la insulinemia y el índice Homa-IR y la presión diastólica.


ABSTRACT Objective To describe the relationship between obesity and proinflammatory variables in the student population of the University of Quindío. Methods A cross-sectional descriptive study in which 155 students participated. Firstly, the glycemia was made by conventional methods, the insulinemia and the cytokines were measured by ELISA; IMC and HOMA-IR index were calculated. Then, the information was analyzed in the Statgraphics software to establish relationships between the variables were established through multiple regression and thus statistically significant difference was considered when the p value was ≤0.05. Results The prevalence of obesity by BMI was of 4.6%, of overweight 20.5% and of abdominal obesity by waist circumference was of 18.5%. The average insulinemia was 8.5 pUI/ml ±6.4 and the HOMA-IR index was 1.75. 18.5% had insulin resistance. Interferon gamma was found at 4.6±12.0 pg/mL, IL-6 at 5.1±15.5 pg/mL and TNF alpha at 3.2±11.1 pg/mL. The greatest variation explained (R2) is presented by insulinemia, the waist/hip index and the Homa-IR index. IL-6 was the cytokine that presented the greatest variation explained. Conclusions There is a relationship between inflammatory cytokines such as IL-6 with the waist/hip index, diastolic pressure, insulinemia and the Homa-IR index.

18.
J Oncol Pract ; 10(2): e73-80, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24424313

RESUMO

PURPOSE: Screening logs have the potential to help oncology clinical trial programs at the site level, as well as trial leaders, address enrollment in real time. Such an approach could be especially helpful in improving representation of racial/ethnic minority and other underrepresented populations in clinical trials. METHODS: The National Cancer Institute Community Cancer Centers Program (NCCCP) developed a screening log. Log data collected from March 2009 through May 2012 were analyzed for number of patients screened versus enrolled, including for demographic subgroups; screening methods; and enrollment barriers, including reasons for ineligibility and provider and patient reasons for declining to offer or participate in a trial. User feedback was obtained to better understand perceptions of log utility. RESULTS: Of 4,483 patients screened, 18.4% enrolled onto NCCCP log trials. Reasons for nonenrollment were ineligibility (51.6%), patient declined (25.8%), physician declined (15.6%), urgent need for treatment (6.6%), and trial suspension (0.4%). Major reasons for patients declining were no desire to participate in trials (43.2%) and preference for standard of care (39%). Major reasons for physicians declining to offer trials were preference for standard of care (53%) and concerns about tolerability (29.3%). Enrollment rates onto log trials did not differ between white and black (P = .15) or between Hispanic and non-Hispanic patients (P = .73). Other races had lower enrollment rates than whites and blacks. Sites valued the ready access to log data on enrollment barriers, with some sites changing practices to address those barriers. CONCLUSION: Use of screening logs to document enrollment barriers at the local level can facilitate development of strategies to enhance clinical trial accrual.


Assuntos
Ensaios Clínicos como Assunto , Oncologia , National Cancer Institute (U.S.) , Seleção de Pacientes , Humanos , Entrevistas como Assunto , Estados Unidos
19.
Ann Clin Lab Sci ; 43(2): 176-80, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23694793

RESUMO

Multiple myeloma (MM) is a plasma cell neoplasm involving the bone marrow with organ damage and/or a monoclonal protein (M-spike in the serum and/or urine). This neoplasm typically affects adults over the age of 50. Acute lymphoblastic leukemia (ALL) is a hematological disorder involving at least 20% lymphoblasts in the bone marrow of the B-cell lineage. Acute lymphoblastic leukemia most commonly affects young children with 75% of cases occurring in children less than 6 years old. This case report describes a patient diagnosed with MM in 2000 who achieved a complete remission in 2006 after chemotherapy. Four years later, the patient presented with sudden pancytopenia. A bone marrow biopsy was obtained revealing a B lymphoblastic leukemia in an extensively fibrotic marrow without evidence of MM. A diagnosis of ALL with myelofibrosis is rare in the adult population, acute myelofibrosis (AMF) is more commonly associated with myeloproliferative disorders, and the development of acute leukemia in myeloma is rare. To the best of our knowledge, the presence of MM, ALL, and myelofibrosis in one patient has never been reported.


Assuntos
Mieloma Múltiplo/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Mielofibrose Primária/patologia , Idoso , Contagem de Células Sanguíneas , Medula Óssea/patologia , Humanos , Imuno-Histoquímica , Lenalidomida , Quimioterapia de Manutenção/efeitos adversos , Masculino , Mieloma Múltiplo/complicações , Leucemia-Linfoma Linfoblástico de Células Precursoras/etiologia , Mielofibrose Primária/etiologia , Talidomida/efeitos adversos , Talidomida/análogos & derivados , Talidomida/uso terapêutico
20.
Resuscitation ; 84(5): 635-8, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23000365

RESUMO

BACKGROUND: Although the occurrence of intraoperative cardiac arrest is rare, it is a severe adverse event with a high mortality rate. Trauma patients have additional causes for intraoperative arrest, and we hypothesised that the survival of trauma patients who experienced intraoperative cardiac arrest would be worse than nontrauma patients who experienced intraoperative cardiac arrest. OBJECTIVES: The aim of the present study was to compare the outcomes of trauma and nontrauma patients after intraoperative cardiac arrest. METHODS: In a tertiary university hospital and trauma centre, the intraoperative cardiac arrest cases were evaluated from January 2007 to December 2009, excluding patients submitted to cardiac surgery. Data were prospectively collected using the Utstein-style. Outcomes among the patients with trauma were compared to the patients without trauma. RESULTS: We collected data from 81 consecutive intraoperative cardiac arrest cases: 32 with trauma and 49 without trauma. Patients in the trauma group were younger than the patients in the nontrauma group (44±23 vs. 63±17, p<0.001). Hypovolaemia (63% vs. 35%, p=0.022) and metabolic/hydroelectrolytic disturbances (41% vs. 2%, p<0.001) were more likely to cause the cardiac arrest in the trauma group. The first documented arrest rhythm did not differ between the groups, and pulseless electrical activity was the most prevalent rhythm (66% vs. 53%, p=0.698). The return of spontaneous circulation (47% vs. 63%, p=0.146) and survival to discharge with favourable neurological outcome (16% vs. 14%, p=0.869) did not differ between the two groups. CONCLUSIONS: The outcomes did not differ between patients with trauma and nontrauma intraoperative cardiac arrest.


Assuntos
Parada Cardíaca/complicações , Complicações Intraoperatórias/epidemiologia , Ferimentos e Lesões/complicações , Ferimentos e Lesões/cirurgia , Adulto , Idoso , Feminino , Parada Cardíaca/etiologia , Parada Cardíaca/mortalidade , Hospitais Universitários , Humanos , Complicações Intraoperatórias/mortalidade , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Alta do Paciente , Prevalência , Prognóstico , Estudos Prospectivos , Taxa de Sobrevida , Ferimentos e Lesões/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA